PAVmed Inc. DEF 14A: Executive Compensation Details

Ticker: PAVM · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1624326

Sentiment: neutral

Topics: executive-compensation, proxy-statement, stock-awards, options-awards

Related Tickers: PAVM

TL;DR

PAVM DEF 14A out: exec comp details for FY24, stock/option awards, unvested award values.

AI Summary

PAVmed Inc. filed a DEF 14A on April 30, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on stock and option awards, year-end equity values of unvested awards, and changes in the value of vested and unvested awards for its principal executive officers.

Why It Matters

This filing provides insight into how PAVmed Inc. compensates its top executives, which can influence investor perception and employee morale.

Risk Assessment

Risk Level: medium — DEF 14A filings often contain information about executive compensation and potential shareholder proposals, which can lead to volatility if controversial.

Key Numbers

Key Players & Entities

FAQ

What is the total compensation for the Principal Executive Officer in 2024?

The filing indicates data points for 'StockAndOptionAwardsFromSummCompMember' and 'YearEndEquityValueOfUnvestedAwardsGrantedDuringYearMember' for 2024, but specific dollar amounts for total compensation are not detailed in the provided snippet.

When was PAVmed Inc. formerly known as PAXmed Inc.?

The date of the former company name change from PAXmed Inc. to PAVmed Inc. was November 5, 2014 (20141105).

What is the SIC code for PAVmed Inc.?

The Standard Industrial Classification (SIC) code for PAVmed Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What is the business address of PAVmed Inc.?

The business address for PAVmed Inc. is 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY 10017.

What type of SEC filing is this?

This is a DEF 14A filing, which is a Definitive Proxy Statement.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding PAVmed Inc. (PAVM).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing